Curanex Pharmaceuticals Inc Increase (Decrease) in Interest Payable, Net
Curanex Pharmaceuticals Inc (CURX) reported Increase (Decrease) in Interest Payable, Net of $4.45 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2026-08-14
- Curanex Pharmaceuticals Inc increase (decrease) in interest payable, net for the quarter ending 2025-06-30 was $3.09K.
- Curanex Pharmaceuticals Inc increase (decrease) in interest payable, net for the quarter ending 2025-03-31 was $1.35K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month |
|---|---|---|
| 2025-06-30 | $3.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $4.45K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $1.35K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |